Pragmatica-Lung Study opens for patient enrollment – NCI

The National Cancer Institute, part of the National Institutes of Health (NIH), has helped launch a phase 3 randomized clinical trial (NCT05633602) of a two-drug combination to treat patients with advanced non-small cell lung cancer (NSCLC). Called the Pragmatica-Lung Study (or S2302), this is one of the first NCI-supported clinical trials to use a trial design that removes many of the barriers that prevent people from joining clinical trials. This “pragmatic” approach aims to increase accessibility to clinical trials.

Source: Pragmatica-Lung Study opens for patient enrollment – NCI

 

IronWynch

My pronouns are whatever you're comfortable with as long as you speak to me with respect. I'm an Afruikan and Iswa refugee living in Canaan. That's African American expat in Israel in Normalian. I build websites, make art, and assist people in exercising their spirituality. I'm also the king of an ile, Baalat Teva, a group of African spirituality adherents here. Feel free to contact me if you are in need of my services or just want to chat.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • You’ve read the article, now get the t-shirt! :-D